Back to Agenda
Session 4 / Venue 5: Development of Regenerative Medicinal Products
Session Chair(s)
Fumiaki Kobayashi, PhD
President
CTD inc., Japan
Thanks to the winning of the Nobel Prize for iPS cells, numerous efforts are now being made for regenerative medicine in academia as well as in the pharmaceutical industry. The development of regenerative medicinal products is however still evolving, with a number of issues remaining to be solved. In this session, we will explain the points to consider from the perspective of review of the regenerative medicinal products and discuss the current development situation, the issues surrounding the development, and how to address such issues from the viewpoint of our industry, the government, and academia.
Speaker(s)
PMDA’s Efforts in Consultation and Review of Cellular and Tissue-based Products
Tetsuya Kusakabe, PhD
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Coordination Director
Development of Regenerative Medicinal Products - Discussion from the Academia’s Position
Akifumi Matsuyama, PhD
Osaka Habikino Medical Center, Osaka Prefectural Hospital Organization, Japan
Regenerative drug-discovery supporting business
Junichi Mineno, PhD
Takara Bio Inc., Japan
Managing Director, President of Bioindustry Business Unit,
Have an account?